4.7 Article

Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors

期刊

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
卷 40, 期 8, 页码 3655-3667

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2020.1848630

关键词

COVID-19; natural products; virtual screening; molecular docking; protease inhibitors

资金

  1. IIT (BHU)

向作者/读者索取更多资源

This study identified potential inhibitors of 2019-nCoV protease using ligand- and structure-based approaches. Through screening and calculations, two compounds with good activity and desirable properties were identified, which could serve as drug candidates against 2019-nCoV.
3CL like protease (3CLpro or Mpro) is one of the main proteases of 2019-nCoV. The 3CLpro is a nonstructural protein of SARS-CoV and has an essential role in viral replication and transcription, thus, could be a potential target for anti-SARS drug development. The present study employed ligand- and structure-based approaches to identify the potent inhibitors of 2019-nCoV protease. The e-pharmacophore developed from 3CLpro-1 yielded virtual hits, that were subjected through drug likeliness and PAINS filters to remove interfering compounds. Further comprehensive docking studies, free energy calculations and ADMET studies resulted in two virtual leads- MolPort-000-410-348 and MolPort-002-530-156. The compounds MolPort-000-410-348 and MolPort-002-530-156 displayed good docking score of -12.09 and -13.38 Kcal/mol and free binding energy of -63.34 +/- 2.03 and -61.52 +/- 2.24 Kcal/mol, respectively. The compounds also exhibited satisfactory predicted ADMET profile and were subjected to molecular dynamic (MD) studies. The MD simulation produced stable complexes of these ligands with 3CLpro protein and ligand RMSD in acceptable limits. Communicated by Ramaswamy H. Sarma

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据